PATZ1 Activators
PATZ1 Activators are a suite of chemical compounds that indirectly foster the functional activity of PATZ1 through discrete signaling pathways. Forskolin, by raising intracellular cAMP, indirectly amplifies PATZ1's transcription regulatory functions through PKA signaling, which may result in phosphorylation of substrates that associate with PATZ1. Similarly, PMA, through PKC activation, could facilitate PATZ1 phosphorylation and thus its transcriptional activity. Ionomycin's modulation of intracellular calcium levels and Trichostatin A's histone deacetylation inhibition could both create an intracellular milieu that favors PATZ1's access to DNA andits regulatory influence. The inhibition of DNA methyltransferases by 5-Azacytidine and the kinase-inhibiting properties of Epigallocatechin gallate (EGCG) may also lead to an environment conducive to PATZ1's binding to gene promoters, thereby enhancing its transcriptional modulation capabilities. LY294002's influence on the PI3K/AKT pathway, PD98059's MEK inhibition, SB203580's blockade of p38 MAPK, and U0126's selective inhibition of MEK1/2 could all indirectly heighten PATZ1's activity by altering the phosphorylation dynamics and signaling environment that PATZ1 operates within.
Moreover, the application of Spermine and Sodium Butyrate, which affect ionic channels and chromatin structure, respectively, can have implications for PATZ1's functionality. Spermine's role in modulating ionic channels may indirectly enhance PATZ1's transcriptional regulatory activity by influencing the nuclear signaling pathways. Sodium Butyrate's inhibition of histone deacetylases may lead to a more accessible chromatin configuration, potentially augmenting PATZ1's gene regulatory influence.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP may enhance PATZ1's role in transcriptional regulation by modulating the PKA signaling pathway, which can phosphorylate substrates that interact with PATZ1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in numerous signaling pathways. PKC activation could lead to enhanced PATZ1 phosphorylation and subsequent increase in its transcriptional activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which may influence PATZ1 activity by affecting calcium-dependent signaling mechanisms that PATZ1 is part of. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor that can lead to a more relaxed chromatin structure, potentially increasing the accessibility of transcription factors like PATZ1 to their target genes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is an inhibitor of DNA methyltransferases, leading to DNA demethylation. Hypomethylated DNA may provide a more accessible landscape for PATZ1 to bind and regulate gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a known kinase inhibitor, by inhibiting competitive kinases, may enhance PATZ1’s signaling by reducing competitive inhibitory phosphorylation, thus potentially increasing PATZ1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may indirectly enhance PATZ1 activity by altering the PI3K/AKT pathway, which could interact with pathways regulated by PATZ1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that may modulate pathways involving PATZ1 by reducing MEK activity, possibly leading to changes in the phosphorylation state of proteins that interact with PATZ1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could shift the signaling balance to favor other pathways in which PATZ1 is involved, by inhibiting p38 MAPK, which could affect PATZ1's activity. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate ionic channels and may influence signaling pathways that affect the functional role of PATZ1 in the nucleus, potentially enhancing its transcriptional regulatory activity. | ||||||